With the analysis among 61 patents, we discovered top 25 key players by total patent application. Abbisko Therapeutics Co., Ltd., BeyondSpring Pharmaceuticals, Inc., Toray Industries, Inc. are dominant in this area. They take 42.62% of the total patent filing.
Abbisko Therapeutics Co., Ltd.
Shanghai Shi, China
Patent: 11
BeyondSpring Pharmaceuticals, Inc.
New York, United States
Patent: 8
Luxembourg, Luxembourg
Patent: 4
Del Mar Pharmaceuticals (BC) Ltd.
British Columbia, Canada
Patent: 4
Basel-Stadt, Switzerland
Patent: 2
Il-Yang Pharmaceutical Co., Ltd.
Gyeonggi-do, South Korea
Patent: 2
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
Agios Pharmaceuticals, Inc.
Massachusetts, United States
Patent: 1
Sanofi-Aventis Deutschland GmbH
With the analysis among 2 patents, we discovered top 2 start-ups by total patent application.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Leto Laboratories Co., Ltd.
Beijing Shi, China
Patent: 1
With the analysis among related 30 patents applied in the last 5 years. We discover 18 most active companies in this area. The fast-growing Abbisko Therapeutics Co., Ltd., National Cancer Center Korea, The First Hospital of Jilin University take 50.00% of patent filing during this period.
Abbisko Therapeutics Co., Ltd.
Shanghai Shi, China
Patent: 11
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 2
The First Hospital of Jilin University
BeyondSpring Pharmaceuticals, Inc.
New York, United States
Patent: 2
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Leto Laboratories Co., Ltd.
Beijing Shi, China
Patent: 1
Shanghai Hansoh Biomedical Co. Ltd.
Shanghai Shi, China
Patent: 1
Del Mar Pharmaceuticals (BC) Ltd.
British Columbia, Canada
Patent: 1
EnGeneIC Molecular Delivery Pty Ltd.
With the analysis among related 30 patents in last 5 years, we discover 16 new entrants. Abbisko Therapeutics Co., Ltd., National Cancer Center Korea, The First Hospital of Jilin University are the most active new entrants in this area.
Abbisko Therapeutics Co., Ltd.
Shanghai Shi, China
Patent: 11
National Cancer Center Korea
Gyeonggi-do, South Korea
Patent: 2
The First Hospital of Jilin University
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Leto Laboratories Co., Ltd.
Beijing Shi, China
Patent: 1
Shanghai Hansoh Biomedical Co. Ltd.
Shanghai Shi, China
Patent: 1
EnGeneIC Molecular Delivery Pty Ltd.
Jiangsu Hansoh Pharmaceutical Co. Ltd.
Jiangsu Sheng, China
Patent: 1
Sichuan Jiuzhang Biochemical Technology Co., Ltd.
With the analysis among 11 patents, we discovered top 5 universities and scientific research institutions by total patent application. Ruprecht-Karls-Universität Heidelberg, Universidad Autónoma de Nuevo León, Shanghai Institute of Materia Medica Chinese Academy of Sciences are dominant in this area. They take 27.27% of the total patent filing.
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 1
Universidad Autónoma de Nuevo León
Nuevo León, Mexico
Patent: 1
Shanghai Institute of Materia Medica Chinese Academy of Sciences
Shanghai Shi, China
Patent: 1
Hebei Sheng, China
Patent: 1
Chinese Academy of Medical Scciences & Peking Union Medical College